A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–49
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Body Mass Index (BMI) of 18.0 to 32.0 kg/m\^2, inclusive. BMI = weight (kg)/\[height(m)\]\^2
You may not be if
Significant acute or chronic medical illness
History of a clinically significant drug rash, Stevens-Johnson Syndrome or Gilbert's Syndrome
Inability to swallow oral medication
Major surgery within 4 weeks of study treatment administration
Clareo Health | A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriate Mini-Tablet Formulations and the Coadministration of the Individual Reference Products in Healthy Adults Under Fed Conditions
